Literature DB >> 9094440

Neuroimmunomodulation in immune privilege: role of neuropeptides in ocular immunosuppression.

A W Taylor1.   

Abstract

The microenvironments of the eye and brain are physiologically adapted to protect their delicate structures and functions from damaging immunogenic inflammation (delayed-type hypersensitivity). This adaptation is immune privilege. Aqueous humor, the fluid filling the ocular anterior chamber, suppresses antigen-stimulated primed T cells from mediating inflammation by inhibiting the production of the proinflammatory lymphokine interferon gamma. This suppression is mediated by immunosuppressive cytokines and neuropeptides constitutively produced in the eye and released into aqueous humor. Cerebrospinal fluid has similar immunosuppressive activities, cytokines, and neuropeptides as aqueous humor, indicating that similar mechanisms may mediate immune privilege in the eye and brain. The importance of neuropeptides in mediating immunosuppression indicates that immunosuppressive neuroimmunomodulation has a role in preventing induction of immunogenic inflammation within immune-privileged tissues.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9094440     DOI: 10.1159/000097271

Source DB:  PubMed          Journal:  Neuroimmunomodulation        ISSN: 1021-7401            Impact factor:   2.492


  6 in total

1.  Decay accelerating factor is essential for successful corneal engraftment.

Authors:  A Esposito; B Suedekum; J Liu; F An; J Lass; M G Strainic; F Lin; P Heeger; M E Medof
Journal:  Am J Transplant       Date:  2010-01-05       Impact factor: 8.086

2.  Injection of an alpha-melanocyte stimulating hormone expression plasmid is effective in suppressing experimental autoimmune uveitis.

Authors:  D J Lee; D J Biros; A W Taylor
Journal:  Int Immunopharmacol       Date:  2009-05-06       Impact factor: 4.932

3.  Activation of NOD2 in vivo induces IL-1beta production in the eye via caspase-1 but results in ocular inflammation independently of IL-1 signaling.

Authors:  H L Rosenzweig; T M Martin; S R Planck; K Galster; M M Jann; M P Davey; K Kobayashi; R A Flavell; J T Rosenbaum
Journal:  J Leukoc Biol       Date:  2008-05-21       Impact factor: 4.962

Review 4.  The injured nervous system: a Darwinian perspective.

Authors:  Zachary M Weil; Greg J Norman; A Courtney DeVries; Randy J Nelson
Journal:  Prog Neurobiol       Date:  2008-06-14       Impact factor: 11.685

Review 5.  Parainflammation, chronic inflammation, and age-related macular degeneration.

Authors:  Mei Chen; Heping Xu
Journal:  J Leukoc Biol       Date:  2015-08-20       Impact factor: 4.962

Review 6.  Targeting the complement system for the management of retinal inflammatory and degenerative diseases.

Authors:  Heping Xu; Mei Chen
Journal:  Eur J Pharmacol       Date:  2016-03-03       Impact factor: 4.432

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.